Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 28, 2020 Off

Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV)

By BusinessWire

CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that…

January 28, 2020 Off

Global Cough Hypersensitivity Syndrome Treatment Market Industry Analysis, Size, Share, Growth, Trends & Forecast, 2019 – 2027 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cough Hypersensitivity Syndrome Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027”…

January 28, 2020 Off

Global Cough Hypersensitivity Syndrome Treatment Market Industry Analysis, Size, Share, Growth, Trends & Forecast, 2019 – 2027 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cough Hypersensitivity Syndrome Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027”…

January 28, 2020 Off

Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis

By BusinessWire

WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced positive topline results from its randomized, vehicle-controlled, pivotal Phase 3 TRuE-AD2 study evaluating the…

January 28, 2020 Off

Pandion Therapeutics Announces Appointment of Don Frail, PhD, to Its Board of Directors

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pandion Therapeutics, Inc., a biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that Don Frail,…

January 28, 2020 Off

Pandion Therapeutics Announces Appointment of Don Frail, PhD, to Its Board of Directors

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pandion Therapeutics, Inc., a biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that Don Frail,…

January 28, 2020 Off

Century Therapeutics Expands Board of Directors and Management Team

By BusinessWire

Former Novartis CEO Joseph Jimenez Joins Board of Directors, Greg Russotti, formerly of Celgene, Named CTO PHILADELPHIA–(BUSINESS WIRE)–Century Therapeutics, a…

January 28, 2020 Off

Ikena Oncology Announces Dosing of First Patient in Phase 1 Study Evaluating IK-175 in Patients with Advanced Solid Tumors

By BusinessWire

Commencement of First-in-Human Clinical Study Within Three Years of Discovery Program Initiation Highlights the Rapid Advancement of This Orally Administered,…

January 28, 2020 Off

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS

By BusinessWire

PROVIDES 2020 FINANCIAL GUIDANCEĀ  Full-Year 2019 Revenues of $51.8 Billion, Reflecting 1% Operational Decline; Excluding the Impact from Consumer Healthcare(1),…

January 28, 2020 Off

Investigation Report on Chinese Pregabalin Market During the Period, 2020-2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Investigation Report on Chinese Pregabalin Market, 2020-2024” report has been added to ResearchAndMarkets.com’s offering. Pregabalin is a new-generation…

Posts pagination

Previous 1 … 5,173 5,174 5,175 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine